Cellivery Therapeutics, Inc.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 2014-03-06
- Employees
- 101
- Market Cap
- -
- Website
- http://www.cellivery.com
iCP-NI - Safety, Tolerability, Pharmacokinetic, and Immunogenicity Study in Healthy Male and Female Subjects
- First Posted Date
- 2023-02-23
- Last Posted Date
- 2023-05-26
- Lead Sponsor
- Cellivery Therapeutics, Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT05740280
- Locations
- 🇺🇸
Labcorp Clinical Research Unit Inc., Daytona Beach, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath